An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Blade Air Mobility to Present at the 50th Annual J.P. Morgan Global Technology, Media and Communications Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Blade Air Mobility, Inc. (NASDAQ: BLDE) announced that CEO Rob Wiesenthal will present at the 50th Annual J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 25, 2022, at 3:10 pm ET. A live webcast will be accessible HERE. Blade focuses on reducing travel congestion by offering cost-effective air transportation solutions, primarily using helicopters and amphibious aircraft.
Positive
None.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Blade Air Mobility, Inc. (“Blade” or the “Company,” NASDAQ: BLDE) a technology-powered global air mobility platform, today announced that Chief Executive Officer, Rob Wiesenthal, will present at the 50th Annual J.P. Morgan Global Technology, Media and Communications Conference on Wednesday, May 25, 2022 at 3:10 pm ET. A webcast of the event will be available at the link HERE. A replay will be available shortly after the conclusion of the presentation on the investor relations section of the company’s website at https://ir.blade.com/news-events.
About Blade
Blade is a technology-powered, global air mobility platform committed to reducing travel friction by providing cost-effective air transportation alternatives to some of the most congested ground routes in the U.S. and abroad. Today, the Company predominantly uses helicopters and amphibious aircraft for its passenger routes and is also one of the largest air medical transporters of human organs for transplant in the world. Its asset-light model, coupled with its exclusive passenger terminal infrastructure, is designed to facilitate a seamless transition to Electric Vertical Aircraft (“EVA” or “eVTOL”), enabling lower cost air mobility to the public that is both quiet and emission-free.
